Koyfin Home > Directory > Health Care > Retrophin Inc > Capital Expenditures

Retrophin Inc Capital Expenditures Chart (RTRX)

Retrophin Inc annual/quarterly Capital Expenditures from 2011 to 2020.
  • Retrophin Inc Capital Expenditures for the quarter ending June 06, 2020 was $0m a 14.52% decrease of 0m year over year
  • Retrophin Inc Capital Expenditures for the last 12 months ending June 06, 2020 was $-1m a 58.67% decrease of 0m year over year
  • Retrophin Inc Annual Capital Expenditures for 2019 was $0m a -272.82% increase of 1m from 2018
  • Retrophin Inc Annual Capital Expenditures for 2018 was $-1m a -22.01% increase of 0m from 2017
  • Retrophin Inc Annual Capital Expenditures for 2017 was $-1m a -60.99% increase of 1m from 2016
Other Cash Flow Metrics:
  • Retrophin Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-4m a -313.30% increase of 11m year over year
  • Retrophin Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-20m a -76.10% increase of 15m year over year
  • Retrophin Inc Total Revenue for the quarter ending September 09, 2018 was $41m a -3.61% decrease of -1m year over year
View Chart On Koyfin

Quarterly RTRX Capital Expenditures Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$-1m
03/2018$0m

Annual RTRX Capital Expenditures Data

2019$0m
2018$-1m
2017$-1m
2016$-1m
2015$0m
2014$-1m
2013$0m
2012$0m
2011$0m